Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 392 participants.
Also called NCT03121209
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 392 participants
- Sponsor
- Registry
-
NCT03121209
-
- Other papers using this trial's data
- Revascularization in Asymptomatic Carotid Artery Stenosis With Hemodynamic Impairment and Cognitive Outcomes: The CREST-H Substudy of the CREST-2 Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT03121209. Randomized; single masking; primary purpose prevention. Start 2018-01-18 (actual); primary completion 2025-09-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)
- Acronym
- CREST-H
- Condition
- Internal Carotid Artery Stenosis
- Condition
- Cognitive Impairment
- Intervention (Procedure)
- Revascularization
- Intervention (Other)
- Intensive Medical Management (IMM) alone
- Lead sponsor
- Columbia University
- Collaborator
- National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator
- Mayo Clinic
- Collaborator
- University of Alabama at Birmingham
- Collaborator
- University of Maryland
- Collaborator
- University of California, Los Angeles
Record details
- Record id
cardio:ct-nct03121209- Content hash
ad8f7aa3c715191856e009d11c6221fa425fce7243d369737f6fdbe91b797d1c